Association of Adherence to a Healthy Diet with Cognitive Decline in European and American Older Adults by Berendsen, A.A.M. (Agnes) et al.
 © 2017 The Author(s)
Published by S. Karger AG, Basel 
 Original Research Article 
 Dement Geriatr Cogn Disord 2017;43:215–227 
 Association of Adherence to a Healthy Diet 
with Cognitive Decline in European and 
American Older Adults: A Meta-Analysis 
within the CHANCES Consortium 
 Agnes A.M. Berendsen a    Jae H. Kang b    Ondine van de Rest a    
Nicole Jankovic c    Ellen Kampman a    Jessica C. Kiefte-de Jong d, e    
Oscar H. Franco d    M. Arfan Ikram d    Hynek Pikhart f    Lena Maria Nilsson g    
Hermann Brenner h, i    Paolo Boffetta j    Snorri Bjorn Rafnsson f, k    
Deborah Gustafson l, m    Andreas Kyrozis n, o    Antonia Trichopoulou n    
Edith J.M. Feskens a    Francine Grodstein b, p    Lisette C.P.G.M. de Groot a  
 a Division of Human Nutrition, Wageningen University & Research,  Wageningen , The 
Netherlands;  b Channing Division of Network Medicine, Department of Medicine, Brigham 
and Women’s Hospital/Harvard Medical School,  Boston, MA , USA;  c Centre of Clinical 
Epidemiology, Institute for Medical Informatics, Biometry and Epidemiology, Faculty of 
Medicine, University Duisburg-Essen,  Essen , Germany;  d Department of Epidemiology, 
Erasmus MC,  Rotterdam ,  e  Global Public Health, Leiden University College,  Leiden , The 
Netherlands;  f  Research Department of Epidemiology and Public Health, University College 
London,  London , UK;  g  Public Health and Clinical Medicine, Nutritional Research, and Arcum, 
Arctic Research Centre at Umeå University,  Umeå , Sweden;  h Division of Clinical Epidemiology 
and Aging Research, German Cancer Research Center (DKFZ), and  i  Network Aging Research, 
University of Heidelberg,  Heidelberg , Germany;  j  Tisch Cancer Institute, Icahn School of 
Medicine at Mount Sinai,  New York, NY , USA;  k  Centre for Primary Health and Social Care, 
Faculty of Social Sciences and Humanities, London Metropolitan University,  London , UK; 
 l NeuroPsychiatric Epidemiology Unit, Institute for Neuroscience and Physiology, University 
of Gothenburg,  Gothenburg , Sweden;  m  Department of Neurology, SUNY-Downstate 
Medical Center,  Brooklyn, NY , USA;  n Hellenic Health Foundation and  o  1st Department of 
Neurology, Medical School, National and Kapodistrian University of Athens,  Athens , Greece; 
 p Department of Epidemiology, Harvard T.H. Chan School of Public Health,  Harvard, MA , USA
 
 Keywords 
 Ageing · Diet · Nutrition · CHANCES · Cognition · Cohort · Epidemiology · Healthy Diet 
Indicator 
 Abstract 
 Aim: To examine the association between a healthy diet, assessed by the Healthy Diet Indica-
tor (HDI), and cognitive decline in older adults.  Methods: Data from 21,837 participants aged 
 ≥ 55 years from 3 cohorts (Survey in Europe on Nutrition and the Elderly, a Concerted Action 
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[SENECA], Rotterdam Study [RS], Nurses’ Health Study [NHS]) were analyzed. HDI scores were 
based on intakes of saturated fatty acids, polyunsaturated fatty acids, mono- and disaccha-
rides, protein, cholesterol, fruits and vegetables, and fiber. The Telephone Interview for Cog-
nitive Status in NHS and Mini-Mental State Examination in RS and SENECA were used to assess 
cognitive function from multiple repeated measures. Using multivariable-adjusted, mixed 
linear regression, mean differences in annual rates of cognitive decline by HDI quintiles were 
estimated.  Results: Multivariable-adjusted differences in rates in the highest versus the low-
est HDI quintile were 0.01 (95% CI –0.01, 0.02) in NHS, 0.00 (95% CI –0.02, 0.01) in RS, and 0.00 
(95% CI –0.05, 0.05) in SENECA with a pooled estimate of 0.00 (95% CI –0.01, 0.01),  I 2 = 0%. 
 Conclusions: A higher HDI score was not related to reduced rates of cognitive decline in Eu-
ropean and American older adults.  © 2017 The Author(s)
Published by S. Karger AG, Basel 
 Introduction 
 The world’s population aged over 60 years is predicted to double from 11 to 22% between 
2000 and 2050  [1] . This demographic shift is likely to further increase the prevalence of age-
related diseases and disabilities in the near future. In 2013, there were 44.4 million people 
with dementia worldwide, and this number will increase to an estimated 135.5 million in 
2050  [2] . Identifying modifiable risk factors for cognitive decline as a precursor of dementia 
is likely to be an important strategy for delaying the onset, and reducing the number of people 
with dementia  [3] ; a healthy diet is hypothesized to reduce risk  [4] . 
 A common approach to explore the impact of nutrition is studying dietary patterns 
comprising combinations of nutrients and foods. A frequently studied dietary pattern is the 
Mediterranean diet, which is rich in fruits and vegetables and unsaturated fatty acids. Greater 
adherence to the Mediterranean diet has been associated with a lower rate of cognitive 
decline in a number of observational and interventional studies  [5] . However, there is a need 
to jointly study information from multiple studies to establish clear associations between a 
healthful dietary pattern, cognitive function, and cognitive decline. 
 Recommending dietary patterns at an international level requires the operationalization 
of globally applicable dietary guidelines. Therefore, the 1990 World Health Organization 
(WHO) guidelines for a healthy diet  [6] were translated into the Healthy Diet Indicator (HDI) 
 [7, 8] . These guidelines were developed to reduce chronic diseases, such as hypertension. As 
hypertension has been shown to impact cognitive function  [9–11] , it has been hypothesized 
that the HDI could reduce cognitive function decline. 
 The HDI based on initial WHO recommendations has been associated with a lower prev-
alence of cognitive impairment  [12, 13] ; however, the association between updated WHO 
guidelines and cognitive decline has not been quantified. We therefore prospectively examined 
the association between baseline HDI and cognitive decline at older age among 21,837 men 
and women from Europe and the US by conducting a meta-analysis of individual participant 
data from 3 population-based cohorts involved in the Consortium on Health and Ageing: 
Network of Cohorts in Europe and the United States (CHANCES)  [14] . We hypothesized that 
a higher HDI score would be related to less cognitive decline.
 Materials and Methods  
 Data Assessment and Harmonization 
 The aim of CHANCES is to combine prospective cohort studies to produce, improve, and clarify the 
evidence on the distribution and risk factors of chronic diseases in the elderly and on their socioeconomic 
impact (www.chancesfp7.eu). Data standardization and harmonization procedures were largely based upon 
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the experience from the MORGAM project and previous experiences of project partners  [15] . Data assessment 
procedures included examination of availability and comparability of cohort data, questionnaires and 
measurement procedures used in the individual cohorts, and methods for collection of data on health 
outcomes  [14, 16] . For the present study, CHANCES cohorts were selected with harmonized variables on 
dietary intake and cognitive function, and covariates according to predefined rules. 
 Study Design and Population 
 We included participants aged  ≥ 55 years from 3 cohorts, namely the cognitive substudy of the Nurses’ 
Health Study (NHS) from the US  [17] ; the Rotterdam Study (RS) from the Netherlands  [18] ; and the Survey 
in Europe on Nutrition and the Elderly, a Concerted Action (SENECA) Study from Europe (Belgium, Denmark, 
France, Italy, The Netherlands, Portugal, Spain, Switzerland, and Poland)  [19] .
 NHS began in 1976, with 121,700 female registered nurses aged 30–55 years  [17] . During 1995–2001, 
women aged  ≥ 70 years were invited to participate in a telephone-based study of cognitive function. For the 
first interview, 93% of eligible women participated ( n = 19,415). Follow-up assessments were performed up 
to 3 times at 2-year intervals. RS began baseline measures between 1990 and 1993 in 7,983 men and women 
aged  ≥ 55 years  [20] . The first follow-up examination took place between 1993 and 1994 in 6,315 partici-
pants (follow-up 88%) and continued in 1997, 1999, and 2001. The total SENECA population consisted of 
2,585 European men and women aged 70–75 years at inclusion in 1988, and 124 participants were addi-
tionally added in a second wave in 1993. Follow-up measures were performed in 1993 and 1998  [19] . In all 
cohorts, the collaborative research procedures were in accordance with the ethical standards of the respon-
sible institutional or regional committees on human experimentation and informed consent was obtained 
from all participants.
 Dietary Assessment 
 Information on dietary intake was obtained with a validated 116-item semiquantitative Food Frequency 
Questionnaire (FFQ) in NHS in 1994 and 1998  [17] and a validated 170-item FFQ in RS at baseline (1990–
1993)  [20] . In SENECA, dietary intake was assessed in 1988 ( n = 2,585) and 1993 ( n = 1,301) by means of a 
dietary history method including a 3-day food record and a frequency checklist of foods  [19] . Participants 
were interviewed by a dietician about their usual food consumption per day during the past month. Food 
intake estimations were converted into nutrient intakes by multiplying the consumption of each food by its 
nutrient content, using the US Department of Agriculture database in NHS and the Dutch food composition 
table (NEVO)  [21] in RS and SENECA. The FFQs and dietary history method provided information allowing 
to estimate usual dietary intake per day during a specified period of time. 
 Healthy Diet Indicator 
 We used dietary intake immediately preceding the first cognitive assessment (ranging from 0 to 3 years 
across the 3 cohorts) to estimate daily energy intake and to assess adherence to the updated WHO dietary 
guidelines in 2003  [8] . From 15 dietary items listed in the guidelines, 7 items from which information was 
available across all cohorts were included in the HDI. This resulted in an HDI including saturated fatty acids, 
polyunsaturated fatty acids (PUFAs), mono- and disaccharides, protein, cholesterol, fruits and vegetables, 
and dietary fiber. Not included in the score were the intake of n-3 PUFAs, n-6 PUFAs, trans-fatty acids, and 
sodium due to unavailability of data across cohorts. Furthermore, as suggested before  [7] , we excluded total 
fat and total carbohydrates from the HDI score calculation to avoid duplicating weights for these 2 compo-
nents by the component factors and excluded nonstarch polysaccharide as it also overlapped with the recom-
mendation for total dietary fiber. We also excluded monounsaturated fatty acids (MUFAs), because the WHO 
guideline does not clearly specify the recommended intake of MUFAs in contrast to other fats. We applied a 
recently developed continuous HDI scoring system  [22] with scores ranging from 0 to 10 per dietary 
component to provide greater variation between individuals and to overcome the use of definite cutoffs  [22] . 
Intakes below the lower cutoff were assigned 0 points and intakes above the upper cutoff were assigned 10 
points. Within a given range of intakes for each component, the range was divided into 10, and points were 
given in proportion to the distance from the 0 point cutoff. The scoring criteria, as well as the median 
component scores by cohort are shown in  Table 1 . Total HDI scores were divided into sex- and cohort-specific 
quintiles based on study population intake distributions.
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 Assessment of Cognitive Function 
 In NHS, the Telephone Interview of Cognitive Status (TICS)  [23] , a telephone adaptation of the Mini-
Mental State Examination (MMSE) was administered first at baseline (1995–2001), then at approximately 
2-year intervals, with up to 3 repeated measures. The TICS contains measures of orientation, immediate 
verbal recall, registration, opposites, current events, serial subtraction, counting, and other elements and 
assesses global cognitive performance, with scores ranging from 0 to 41.
 The MMSE  [24] assessed global cognitive function in RS in 1990, 1993, 1997, 1999, and 2001, and in 
SENECA in 1993 and 1999. The MMSE includes questions on orientation to time and place, registration, 
attention and calculation, recall, language, and visual construction, resulting in a score from 0 to 30. A corre-
lation of 0.94 between TICS and MMSE and a high test-retest reliability for TICS ( r =  0.97) was reported  [23] . 
Higher TICS or MMSE scores indicate better cognitive performance.
 We calculated  z -scores at each time point using cohort-specific distributions of scores at first cognitive 
assessment allowing comparability of findings across cohorts.
 Other Variables 
 Demographic, health, and lifestyle information was obtained from self-administered questionnaires. 
Height and weight were measured at baseline in RS and SENECA and self-reported in NHS  [25] . Physical 
activity was assessed by validated questionnaires for elderly by estimating mean energy expended per week 
in NHS (in metabolic equivalent-hours, METs) and as being vigorously physically active in SENECA and RS. 
In RS, physical activity was assessed 6 years after baseline as no baseline measure was available. Prevalence 
of diabetes mellitus, myocardial infarction, high blood pressure, depression, and hypercholesterolemia was 
obtained by questionnaires. In SENECA, hypercholesterolemia was estimated on use of dyslipidemia medica-
tions.
 Population for Analysis 
 We excluded participants with incomplete dietary intake data ( n = 2,144 NHS,  n = 2 RS,  n = 16 SENECA), 
without at least 1 cognitive assessment ( n = 1,771 RS,  n = 1,676 SENECA), and missing data for physical 
activity ( n = 111 NHS,  n = 1,769 RS), resulting in a total population of 21,837 participants (17,160 NHS, 3,660 
RS, and 1,017 SENECA).
 Statistical Analyses 
 Means and standard deviations were calculated for normally distributed continuous variables, and 
numbers and percentages were calculated for categorical variables.
 In the primary approach, we modelled trajectories of repeated cognitive measures using linear mixed 
models  [26] , with follow-up time from baseline as the time metameter. The linear model included an intercept 
representing the baseline level of cognitive score and a slope representing annual cognitive change as well 
 Table 1.  Scoring criteria of the HDI components based on the WHO’s 2003 guidelines for a healthy diet and mean component 
intakes by country and sex
HDI componenta 0
points
0 – 10
pointse
10
points
NHS (women) RS  SENECA
men women m en women
Saturated fatty acids, en%b, c >15 ≥10–≤15 0–<10 9.3 (2.8) 14.9 (3.1) 14.7 (3.3) 14.3 (4.4) 14.8 (4.4)
Mono- and disaccharides, en%b–d >30 ≥10–≤30 0–<10 27.3 (7.3) 21.6 (6.2) 22.7 (5.9) 19.1 (6.5) 20.3 (7.1)
Cholesterol, mg/dayc >400 ≥300–≤400 0–<300 181.5 (88.4) 259.1 (88.8) 215.5 (69.2) 314.9 (132.2) 272.0 (121.9)
Polyunsaturated fatty acids, en%b, c >10 0–<6 ≥6–≤10 5.6 (1.8) 7.6 (2.9) 6.9 (2.8) 6.2 (3.9) 6.2 (3.2)
Protein, en%b >20 0–<10 or
>15–≤20
≥10–≤15 17.0 (3.2) 17.0 (2.9) 17.9 (3.2) 15.1 (2.7) 15.1 (3.2)
Total dietary fiber, g/day 0 0–<25 ≥25 5.4 (2.2) 18.3 (5.3) 16.2 (4.5) 22.2 (7.7) 18.5 (6.6)
Fruits and vegetables, g/day 0 0–<400 ≥400 400.8 (206.6) 429.0 (170.3) 461.8 (180.1) 563.3 (257.5) 497.3 (213.5)
 HDI, Healthy Diet Indicator; WHO, World Health Organization; NHS, Nurses’ Health Study; RS, Rotterdam Study; en%, energy percent. Values are mean (SD).
a Standard in accordance with WHO guidelines. The joint WHO Food and Agriculture Organization of the United Nations guidelines of 2003 do not clearly indicate 
fiber cutoff values. Fulfillment of the fruit and vegetable recommendation and consumption of whole grains should sum to 20 g of nonstarch polysaccharides, which 
equals approximately 25 g of dietary fiber. Total fat and total carbohydrates were excluded to avoid overlap with other components of the score. b Calculated without 
energy from alcohol. c The cutoff value at which a participant would score 0 points was based on the 85th percentile of the population’s intake distribution. 
Calculation of points for dietary intake between the upper limit and the standard intake for maximum number of points: 10 – (intake – recommendation upper limit) 
× (10/standard upper limit – recommendation upper limit). d Mono- and disaccharides were studied instead of free sugars. e The range was divided into 10 and then 
points were given in proportion to the distance from the 0 point cutoff.
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as a random intercept and random slope accounting for interindividual variability. Linear trends across quin-
tiles of HDI score were examined using a continuous variable in which participants in a given HDI quintile 
were assigned the median value.
 In a secondary approach, all repeated measures of cognitive function were averaged to create an 
outcome representing long-term cognitive status. Averaging repeated measures of cognition attenuates vari-
ability in each single cognitive assessment, which may be helpful when cognition is measured over a rela-
tively short follow-up period with a modest decline over time in healthy, educated participants in NHS, RS, 
and SENECA  [17, 27] . Mean differences in cognitive status across quintiles of HDI score were modelled using 
linear regression. 
 Adjustments were made for confounding factors that have been related to both dietary intake and 
cognitive function: age, sex, education (low, middle, high) (model 1), and employment history (employed, 
housekeeper, unemployed/retired), BMI (<22, 22–25,  ≥ 25–30,  ≥ 30 kg/m 2 ), smoking status (never, former, 
current), energy intake (cohort specific quintiles), alcohol intake (<1, 1–14.9,  ≥ 15 g/day), physical activity 
(yes/no vigorous exercise in RS and SENECA, quintiles of METS in NHS), and depression (yes/no) (model 2). 
Vascular conditions (history of diabetes [yes/no], myocardial infarction [yes/no], high blood pressure [yes/
no], and hypercholesterolemia [yes/no]) were tested as mediators by adding them to the full model (model 
3). In the linear regression model studying long-term cognitive status, a study center variable was added to 
SENECA to adjust for differences in baseline MMSE score between study centers. For BMI, 4.4% was missing 
in NHS; for employment, data were missing for 3.7% in RS; in SENECA, data were missing for education 
(5.9%) and depression (15%); thus, a specific missing category was created for these 4 variables. For all other 
covariates, participants with missing information were <1% of the sample and were assigned to the reference 
group. In subgroup analyses, we repeated our primary analyses while stratifying by sex (not applicable in 
NHS), baseline cognitive function (worst 10% vs. best 90%), age (median split), BMI (<25 vs.  ≥ 25), and 
having any major cardiovascular risk factor (high blood pressure, hypercholesterolemia, myocardial 
infarction). As a sensitivity analysis, we determined the potential impact on our estimates of a learning effect 
when participants are administered the same cognitive tests multiple times by averaging the first 2 cognitive 
assessments within NHS and RS to derive a more robust baseline measure variable as first cognitive 
assessment and then repeating our analysis. 
 Subsequently, we summarized the multivariable-adjusted mean differences in slopes of the fifth quintile 
versus first quintile per cohort by random effects pooling by using DerSimonian and Laird random effects 
models  [28] , accounting for differences in sample size and the possibility of statistical heterogeneity among 
the studies. Between-study heterogeneity was assessed using the  I 2 statistic  [29] , expressing the percentage 
of variation attributable to between-study heterogeneity. All statistical analyses were carried out using SAS, 
version 9.3, software (SAS Institute Inc., Cary, NC, USA). For random effects meta-analyses, we used the 
 metaphor package in R, version 3.2.0 (R Foundation for Statistical Computing, Vienna, Austria).  p values <0.05 
were considered significant. 
 Results 
 General Characteristics 
 Median HDI scores were 44.6 (range 13.3–62.5) in NHS, 45.5 (range 14.4–62.9) in RS, and 
47.9 (range 20.6–69.9) in SENECA. At the first cognitive assessment, mean age of participants 
was 74.2 (2.3) years in NHS, 65.7 (7.3) in RS, and 78.0 (2.8) in SENECA. Across all cohorts, 
participants with a higher HDI score were more likely to be physically active, higher educated, 
never smokers, normal weight, to have higher energy intakes, and a history of myocardial 
infarction and to be less likely to have a history of diabetes ( Table 2 ). 
 Relation between HDI Score and Cognitive Decline 
 A higher HDI score was not associated with cognitive decline in the basic adjusted model 
(adjusted mean differences in rates between extreme quintiles = 0.005 [95% CI –0.005, 0.016], 
 p trend = 0.17 in NHS, 0.001 [95% CI –0.014, 0.015],  p trend = 0.69 in RS, and 0.008 [95% CI 
–0.041, 0.052],  p trend = 0.49 in SENECA), or in the multivariable-adjusted model (0.005, [95% 
CI –0.006, 0.016]),  p trend = 0.20 in NHS, –0.002 [95% CI –0.016, 0.013],  p trend = 0.98 in RS 
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 Table 2. Baseline characteristics of participants in the NHS (n = 17,160), RS (n = 3,660) and SENECA (n = 1,017) by extreme 
cohort- and sex-specific quintiles of HDI score
NHS RS SENECA
quintile 1 quintile 5 quintile 1 quintile 5 quintile 1 quintile 5
(n = 3,422) (n = 3,431) (n = 731) (n = 731) (n = 202) (n = 203)
HDI score 35.7
[32.6 – 37.7]
52.7
[51.4 – 54.4]
36.4
[33.8 – 38.2]
53.2
[51.9 – 55.2]
38.1
[35.4 – 40.2]
57.1
[55.3 – 59.23]
Age, years 74.1 (2.3) 74.4 (2.4) 66.3 (7.4) 65.6 (6.3) 77.8 (2.8) 78.0 (2.8)
Men N/A N/A 40.8 40.8 49.0 48.8
Educational level
Low 78 77 34 29 53 49
Middle 16 16 57 60 30 33
High 6 6 8 11 10 10
BMI
≤21 19 22 8 11 9 12
22 – 24 24 27 28 34 22 20
25 – 29 33 34 50 44 43 44
≥30 20 14 15 12 20 14
Physical activitya 13.8 (18.7) 18.3 (22.1) 83 89 8 9
Employment history
Employed 5 4 79 78 75 78
Homemaker 7 7 11 9 17 12
Other/retired 88 89 10 13 9 10
Smoking
Never 44 48 30 36 55 60
Former 44 46 39 46 30 30
Current 12 6 31 18 15 10
History of disease
Myocardial infarction 6 5 9 11 24 32
Hypertension 56 55 36 37 32 37
Hypercholesterolemia 60 67 2 3 11 6
Diabetes 11 9 9 6 16 13
Depression 10 9 9 9 19 19
Dietary variables
Energy intake, kcal 1,518 (572) 1,806 (497) 2,007 (609) 2,053 (414) 1,897 (618) 2,071 (607)
Alcohol, g 5.3 (10.4) 4.6 (8.6) 12.1 (15.8) 7.46 (10.6) 12.6 (18.1) 10.7 (8.9)
HDI components
Saturated fatty acids 11.7 (3.2) 8.1 (1.7) 16.9 (3.1) 13.1 (2.5) 16.6 (4.4) 12.2 (3.6)
PUFAs 5.5 (2.3) 6.3 (1.4) 6.5 (3.6) 7.7 (1.7) 6.3 (4.1) 6.4 (2.2)
Mono- and disaccharides 26.2 (7.8) 26.2 (6.1) 21.5 (6.1) 23.2 (6.0) 20.8 (7.3) 17.9 (6.3)
Protein 18.5 (3.5) 15.0 (1.9) 18.6 (3.3) 16.2 (2.4) 16.9 (3.9) 13.9 (1.7)
Cholesterol, g 221 (121) 166 (68) 285 (105) 204 (55) 351 (144) 239 (78.5)
Fruit and vegetables, g 286 (172) 505 (205) 395 (193) 500 (149) 465 (246) 604 (255)
Dietary fiber, g 4.1 (1.9) 6.8 (2.3) 14.6 (4.7) 20.1 (4.4) 17.0 (6.9) 23.9 (7.5)
MMSE/TICS 33.8 (2.7) 33.8 (2.7) 27.9 (1.5) 28.1 (1.6) 26.9 (2.7) 26.3 (2.7)
HDI, Healthy Diet Indicator; NHS, Nurses’ Health Study; RS, Rotterdam Study; PUFAs, polyunsaturated fatty acids. Data are presented 
as median [IQR], mean (SD), or %. a Physical activity in NHS represented in metabolic-equivalent hours, in RS and SENECA as % vigorous 
physical activity. Dietary variables represent mean intakes per day expressed in energy percentages, unless otherwise noted.
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 Table 3. Multivariable-adjusted mean differences in annual rates of cognitive change by cohort- and sex-
specific quintiles of baseline HDI score
Model 1a Model 2b
NHS (n = 17,160)
Quintile 1 Ref. Ref. 
Quintile 2 –0.004 (–0.014, 0.006) –0.004 (–0.014, 0.007)
Quintile 3 0.013 (0.003, 0.023) 0.012 (0.002, 0.023)
Quintile 4 0.002 (–0.008, 0.012) 0.002 (–0.009, 0.012)
Quintile 5 0.005 (–0.005, 0.016) 0.005 (–0.006, 0.016)
p trend 0.17 0.20
RS (n = 3,660)
Quintile 1 Ref. Ref.
Quintile 2 0.000 (–0.014, 0.015) 0.000 (–0.015, 0.014)
Quintile 3 0.012 (–0.003, 0.026) 0.010 (–0.004, 0.025)
Quintile 4 0.004 (–0.011, 0.018) 0.002 (–0.013, 0.016)
Quintile 5 0.001 (–0.014, 0.015) –0.002 (–0.016, 0.013)
p trend 0.69 0.98
SENECA (n = 1,017)
Quintile 1 Ref. Ref.
Quintile 2 –0.015 (–0.063, 0.034) –0.029 (–0.079, 0.019)
Quintile 3 0.022 (–0.028, 0.071) 0.017 (–0.033, 0.066)
Quintile 4 0.006 (–0.043, 0.055) 0.000 (–0.049, 0.049)
Quintile 5 0.008 (–0.041, 0.057) 0.002 (–0.047, 0.052)
p trend 0.49 0.52
HDI, Healthy Diet Indicator; NHS, Nurses’ Health Study; RS, Rotterdam Study; Ref., reference. Values are 
mean differences (95% confidence interval). a Adjusted for age, gender, and education. b Additionally adjusted 
for employment status, BMI, smoking status, energy intake, alcohol intake, physical activity, and depression.
Cohort (region)
NHS (America)
RS (Netherlands)
SENECA (Europe)
Overall, I2 = 0%
Mean difference (95% CI)
0.005 (–0.006, 0.016)
–0.002 (–0.016, 0.012)
0.002 (–0.047, 0.052)
0.002 (–0.006, 0.011)
–0.06 –0.04 –0.02 0 0.02 0.04 0.06
 Fig. 1. Cohort- and sex-specific and pooled mean differences in the annual rate of cognitive change in relation 
to highest vs. lowest quintile of adherence to the WHO guidelines and cognitive decline, adjusted for age, gen-
der (TS and SENECA), education, employment status, BMI, smoking status, calorie intake, alcohol intake, phys-
ical activity, and depression in the Consortium on Health and Ageing: Network of Cohorts in Europe and the 
United States (CHANCES), 1988–2011. Cohorts are ordered according to cohort size, beginning with the larg-
est cohort.  I 2 is expressed as the percentage of total variability caused by heterogeneity. All data were obtained 
from CHANCES (www.chancesfp7.eu). Bars indicate 95% confidence intervals (CIs). NHS, Nurses’ Health 
Study; RS, Rotterdam Study; SENECA, Survey in Europe on Nutrition and the Elderly, a Concerted Action. 
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and 0.002 [95% CI –0.047, 0.052],  p trend = 0.52 in SENECA) ( Table 3 ). Pooled analyses 
showed no association between highest HDI scores and cognitive decline (pooled multi-
variable-adjusted mean difference = 0.002 [95% CI: –0.006, 0.011],  I 2 = 0%) ( Fig. 1 ). Adding 
mediators to the model (type 2 diabetes mellitus, myocardial infarction, hypertension, and 
hypercholesterolemia) did not affect the estimates (adjusted mean differences in rates 
between extreme quintiles 0.006 [95% CI –0.005, 0.017],  p trend = 0.15 in NHS, –0.002 [95% 
CI –0.017, 0.012],  p trend = 0.98 in RS, and –0.001 [95% CI –0.049, 0.048],  p trend = 0.56 in 
SENECA, respectively). Subgroup analyses by sex, baseline cognitive function, age, and BMI 
did not show differences by strata or statistical interaction. Among those with a history of 
cardiovascular risk factors, there was less cognitive decline with the highest HDI score in 
SENECA ( p trend = 0.03,  p interaction = 0.03;  Table 4 ). Furthermore, in sensitivity analyses 
to address practice effects, in the RS and NHS where >2 repeated measures were available, 
we used models where the average of the first 2 cognitive assessments was considered as the 
new baseline from which cognitive change was evaluated; the results did not differ from the 
main analyses (data not shown).
 Relation between the HDI Score and Cognitive Status 
 The HDI score was not associated with cognitive status in NHS, RS, and SENECA in the 
basic adjusted model ( p trend = 0.28 in NHS, 0.19 in RS, and 0.34 in SENECA), or in the multi-
variable-adjusted model ( p trend = 0.87 in NHS, 0.27 in RS, and 0.25 in SENECA) ( Table 5 ). 
 Discussion 
 In the present consortium study, including 21,837 older men and women from Europe 
and the US, we found that a healthier diet adhering to the most recent WHO guidelines was 
not associated with a slower rate of cognitive decline, nor with cognitive status at older ages, 
which is in contrast to the findings between other dietary patterns  [30–32] and cognition.
 As the HDI was developed to prevent chronic diseases, we hypothesized that it could also 
impact cognitive function. Previously, 2 cross-sectional studies assessed the association 
between a higher HDI score and cognitive impairment and reported a lower prevalence of 
cognitive impairment in 1,049 Italian older men (odds ratio 0.75 [95% CI 0.58–0.97]  [13] ) 
 Table 4. Multivariable-adjusted mean differences in annual rates of cognitive change by cohort- and sex-
specific quintiles of baseline HDI score by cardiovascular risk factor history in SENECA
No cardiovascular risk factor Cardiovascular risk factor
(n = 495) (n = 522)
Quintile 1 Ref. Ref.
Quintile 2 –0.077 (–0.149, –0.005) 0.022 (–0.045, 0.087)
Quintile 3 –0.053 (–0.128, 0.021) 0.076 (0.010, 0.142)
Quintile 4 –0.061 (–0.132, 0.010) 0.076 (0.009, 0.143)
Quintile 5 –0.048 (–0.122, 0.027) 0.056 (–0.009, 0.121)
p trend 0.23 0.03
p interaction 0.03
HDI, Healthy Diet Indicator; Ref., reference. Cardiovascular risk factor or disease included high blood 
pressure, hypercholesterolemia, or myocardial infarction. Values are mean differences (95% confidence 
interval). Scores were adjusted for age, education, study center, employment status, BMI, smoking status, 
energy intake, alcohol intake, physical activity, and depression.
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and in a group of 1,651 Italian older men and women (odds ratio 0.85 [95% CI 0.77–0.93] 
 [12] ). Our study, using a much larger population, a prospective design, and the updated HDI 
guidelines, did not confirm previous findings.
 The lack of significant associations could be a result of low variability in cognitive function 
as measured by the MMSE and TICS due to the ceiling effects of these tests. Future studies on 
cognitive functioning should preferably include tests that are able to measure areas of 
cognition most affected by common dementing illnesses, such as memory, attention, language 
and visuospatial abilities  [33] . However, in our cohorts, we have observed associations be-
tween major risk factors and cognitive change based on TICS  [34–38] . Two previous studies 
examining the initial HDI guidelines used the MMSE  [13] and an extended and validated 
version of the MMSE, namely the 0- to 70-point neuropsychological test  [12] , to assess 
cognitive function. Although these tests are comparable to the tests that we used, the outcome 
was differently defined. We studied cognitive function and cognitive decline, whereas the 
previous studies evaluated cognitive impairment based on predefined cutoffs. This latter 
approach does not allow a distinction between initial level and change  [33] . Furthermore, as 
our cohorts included relatively healthy, well-educated participants compared to the other 
populations  [12, 13] , it is possible that our participants reported healthy diets at baseline 
with an overall good cognitive functioning, limiting the ability to detect an association between 
the HDI and cognitive decline. Nonetheless, we had extremely high ability to identify even 
modest associations given our very large sample size. Previous studies used the initial HDI 
 Table 5. Multivariable-adjusted mean differences in average cognitive status by cohort- and sex-specific 
quintiles of baseline HDI score
Model 1a Model 2b
NHS (n = 16,807)
Quintile 1 Ref. Ref.
Quintile 2 0.00 (–0.04, 0.05) –0.02 (–0.06, 0.03)
Quintile 3 0.04 (–0.01, 0.08) 0.01 (–0.03, 0.06)
Quintile 4 0.00 (–0.04, 0.05) –0.02 (–0.07, 0.02)
Quintile 5 0.03 (–0.02, 0.07) 0.00 (–0.04, 0.04)
p trend 0.28 0.87
RS (n = 3,660)
Quintile 1 Ref. Ref.
Quintile 2 0.02 (–0.08, 0.12) 0.01 (–0.09, 0.11)
Quintile 3 0.06 (–0.04, 0.16) 0.04 (–0.06, 0.14)
Quintile 4 0.06 (–0.04, 0.15) 0.04 (–0.06, 0.14)
Quintile 5 0.06 (–0.04, 0.15) 0.06 (–0.04, 0.15)
p trend 0.19 0.27
SENECA (n = 1,017)
Quintile 1 Ref. Ref.
Quintile 2 0.00 (–0.19, 0.19) –0.02 (–0.21, 0.18)
Quintile 3 0.25 (0.06, 0.45) 0.25 (0.05, 0.44)
Quintile 4 0.01 (–0.19, 0.20) –0.01 (–0.20, 0.19)
Quintile 5 –0.12 (–0.31, 0.08) –0.14 (–0.34, 0.06)
p trend 0.34 0.25
HDI, Healthy Diet Indicator; NHS, Nurses’ Health Study; RS, Rotterdam Study; Ref., reference. Variables 
are mean differences (95% confidence interval). a Adjusted for age, gender, education, and study center 
(SENECA only). b Additionally adjusted for employment status, BMI, smoking status, energy intake, alcohol 
intake, physical activity, and depression.
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including pulses and nuts, which were not part of the updated HDI. While we did not include 
nuts and pulses from the original HDI, the nutrients that would be neuroprotective from these 
foods, such as MUFAs, PUFAs, protein and fiber, would have been captured by the updated 
HDI, making it less likely that the omission of these 2 foods would explain the null findings.
 Another point to consider is that due to the limited amount of dietary information across 
the 3 cohort studies, we included 7 out of 10 HDI components. However, we aimed to increase 
variability within the HDI score by using the recently developed continuous calculation 
system based on 7 dietary components (range 0–70 points) as proposed by Jankovic et al. 
 [22] . It has been shown that using 7 components rather than 10 HDI components (where 
instead of polyunsaturated fat in the 7-component HDI model, n-3 PUFAs, n-6 PUFAs are used 
in addition to trans-fatty acids and sodium) resulted in less heterogeneity when studying the 
HDI in multiple cohort studies  [22] . To test the effect of using 7 HDI components only compared 
to using 10 HDI components, we studied 10 HDI components in NHS and found similar null 
findings, indicating this probably does not explain our null findings. 
 Other dietary patterns that have been shown to be related to cognitive function and 
decline in European and American observational studies in older adults include the Mediter-
ranean diet  [17, 39–46] , the Dietary Approaches to Stop Hypertension (DASH) diet  [42, 44, 
47] , and the Healthy Eating Index (HEI)  [45, 48] . Dietary intervention studies with the Medi-
terranean diet  [30, 31] and the DASH diet  [32] confirmed these findings. These food-based 
scores include high intakes of vegetables, fruits, legumes, whole grains, nuts, fish, MUFAs, 
PUFAs, moderate amounts of low-fat dairy products and alcohol and low amounts of red and 
processed meats, and the MUFA-to-saturated fats ratio. 
 More recently, dietary components linked to neuroprotection and cognitive function 
have been summarized into 1 dietary pattern score, namely the Mediterranean-DASH Inter-
vention for Neurodegenerative Delay (MIND) diet  [49] . The MIND diet is a hybrid of the Medi-
terranean-DASH diets and includes high intakes of green leafy vegetables, other vegetables, 
nuts, berries, beans, whole grains, fish, poultry, olive oil, and wine and low amounts of red 
meats, butter and stick margarine, cheese, pastries and sweets, and fried/fast food. This diet 
has been related to slower cognitive ageing in a single study of 960 older adults (mean age 
81.4 years) of the Memory and Aging Project  [49] . As the HDI does not include the majority 
of these components  [8] , or specific components shown to be associated with cognitive 
function, such as green leafy vegetables  [36, 50] and berries  [34] , it could be that the HDI was 
well-designed to reduce the risk of chronic diseases in general, but not cognitive function. In 
contrast, the inclusion of very specific food items limits the possibility to jointly study effect 
estimates of multiple studies and to target multiple diseases at once by means of 1 dietary 
pattern, as does the HDI. 
 In stratified analyses, we observed less cognitive function decline with higher HDI scores 
in participants reporting a history of cardiovascular risk factors in SENECA. As the HDI has 
been developed to prevent chronic diseases, including hypertension, and as hypertension has 
been associated with a worse cognitive function  [9–11] , it was hypothesized that this group 
at high-risk for cognitive decline would benefit from a healthy diet such as the HDI. Biologi-
cally, the blood pressure-lowering effect of the HDI reduces thickening of the vessel wall, 
leading to less vascular narrowing, resulting in less thickening of the media and atheromatous 
plaques within larger cerebral arteries. This could result in a lower risk of rupture of these 
plaques which could cause complete occlusion of arteries and infarction of surrounding 
tissues  [51] . 
 The availability of harmonized dietary intake variables is a major strength of the present 
study. Furthermore, the use of harmonized outcome variables and covariates reduces hetero-
geneity. Additionally, 4 HDI components are expressed as energy percentage, increasing the 
comparability of diet between different cohorts using different dietary assessment methods. 
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Another advantage is the relatively long follow-up time of cognitive function with multiple 
repeated measures (NHS and SENECA 6 years, RS 10 years), which could have been sufficient 
to measure changes in cognitive function, as other studies were able to measure changes in 
cognitive function after 4–5 years of follow-up  [39, 52] . Another strength is that we were able 
to study changes in cognitive function over time, allowing us to use all available data of all 
cohorts using a comparable measure across cohorts. Finally, studying dietary intake prior to 
the cognitive assessments including many years of follow-up minimized possible reverse 
causation.
 It may be considered a limitation that we used 1 dietary intake assessment, assuming 
stable diets over time. Additional analyses confirmed that dietary intakes were similar over 
multiple time points in NHS and SENECA (data not shown). Furthermore, FFQs rely on partic-
ipants’ estimates of food intake, which can lead to misclassification of dietary pattern 
adherence. This is a common limitation of studies of diet, and our results from SENECA using 
a dietary history method did not result in different conclusions. Lastly, although we have tried 
to differentiate between a healthy lifestyle and a healthy diet by extensively adjusting for risk 
factors for cognitive decline, residual confounding remains possible due to unmeasured or 
imprecisely measured covariates.
 We demonstrated that greater adherence to the WHO dietary guidelines for a healthy diet 
was not associated with reduced rates of cognitive decline in European and American older 
adults.
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